Trial Profile
A long-term renal safety study to evaluate the pemetrexed/cisplatinum in patients with advanced malignant peritoneal mesothelioma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2015
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Pemetrexed (Primary) ; Carboplatin; Cyclophosphamide
- Indications Malignant-mesothelioma
- Focus Therapeutic Use
- 19 Oct 2015 New trial record
- 06 Sep 2015 Results published in 16th World Conference on Lung Cancer